Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+52Malignant Bladder Neoplasm+24Malignant Laryngeal Neoplasm+24Cutaneous Melanoma+20Malignant Esophageal Neoplasm+16Malignant Salivary Gland Neop…+16Malignant Pancreatic Neoplasm+12Malignant Prostate Neoplasm+12Malignant Kidney Neoplasm+8Malignant Mesothelioma+8Malignant Liver Neoplasm+4Malignant Testicular Neoplasm+4Malignant Lung Neoplasm0Malignant Thyroid Gland Neopl…0Malignant Hypopharyngeal Neop…-4
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+52100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21672
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
92
activityPercentile
40

ranking row 2601351

2=Malignant Bladder Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11587
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
72
activityPercentile
48

ranking row 2601353

2=Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2984
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2601352

4=Cutaneous Melanoma+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5811
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
44
activityPercentile
24

ranking row 2601354

5=Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12187
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2601355

5=Malignant Salivary Gland Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
683
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
28
activityPercentile
12

ranking row 2601356

7=Malignant Pancreatic Neoplasm+1276Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21392
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
88
activityPercentile
76

ranking row 2601357

7=Malignant Prostate Neoplasm+1276Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
28848
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2601358

9=Malignant Kidney Neoplasm+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9502
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
64
activityPercentile
56

ranking row 2601360

9=Malignant Mesothelioma+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1890
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2601359

11=Malignant Liver Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
17414
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
84
activityPercentile
80

ranking row 2601361

11=Malignant Testicular Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
374
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
8
activityPercentile
4

ranking row 2601362

13=Malignant Lung Neoplasm052Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
83645
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2601363

13=Malignant Thyroid Gland Neoplasm052Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
884
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
32
activityPercentile
32

ranking row 2601364

15=Malignant Hypopharyngeal Neoplasm-444Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
304
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
4
activityPercentile
8

ranking row 2601365

15=Malignant Penile Neoplasm-444Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
301
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
4

ranking row 2601366

15=Malignant Rectal Neoplasm-444Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5836
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
48
activityPercentile
52

ranking row 2601367

18=Leukemia-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13349
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
88

ranking row 2601368

18=Malignant Anal Neoplasm-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
417
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
12
activityPercentile
20

ranking row 2601370

18=Malignant Gastric Neoplasm-832Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6753
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
56
activityPercentile
64

ranking row 2601369

21=Hodgkin Lymphoma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
655
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
24
activityPercentile
36

ranking row 2601371

21=Malignant Central Nervous System Neoplasm-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9119
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
60
activityPercentile
72

ranking row 2601372

23=Multiple Myeloma-1612Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6723
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
52
activityPercentile
68

ranking row 2601373

24=Malignant Nasopharyngeal Neoplasm-248Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
483
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
20
activityPercentile
44

ranking row 2601375

24=Non-Hodgkin Lymphoma-248Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11381
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
68
activityPercentile
92

ranking row 2601374

26=Malignant Breast Neoplasm-800Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
463
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
16
activityPercentile
96

ranking row 2601376

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 0716fedd43ddd4c61b64278b